Stock Events

Stock Events

Cytosorbents 

$0.3501
17
+$0.00+0.03% 20:00 Today
-$0.00-0.26%20:39After hours

Statistics

Day High
0.3697
Day Low
0.3366
52W High
1.04
52W Low
0.3
Volume
437,109
Avg. Volume
238,276
Mkt Cap
22M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.08
-0.04
-0.01
0.03
Expected EPS
-0.045
Actual EPS
N/A

Financials

-22.12%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
37.06MRevenue
-8.2MNet Income

Analyst Ratings

10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CTSO. It's not an investment recommendation.
Rigetti Computing
6
RGTI
Teucrium Wheat Fund
5
WEAT
Realty Income
4
O
NVIDIA
4
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap13.51B
Baxter International offers a range of dialysis products and acute therapies, directly competing with Cytosorbents' blood purification solutions.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers products for dialysis and blood management, competing in the broader market of medical devices for critical care, similar to Cytosorbents.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation, through its subsidiary Cytiva, provides products and services for life sciences research, competing in the bioprocessing space with Cytosorbents.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation competes in the medical devices sector, offering products that could be used in similar clinical settings as Cytosorbents' therapies.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation manufactures medical devices and equipment, including products for intensive care, which could be seen as complementary or competitive to Cytosorbents' offerings.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products, competing in the broader healthcare and medical device market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including areas relevant to Cytosorbents' market.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the critical care space where Cytosorbents operates.
SeaStar Medical
ICU
Mkt Cap13.62M
ICU Medical provides infusion therapy and critical care products, competing in the market for medical devices and technologies for critical patient care.

About

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Show more...
CEO
Phillip Chan
Employees
129
Country
United States
ISIN
US23283X2062
WKN
000A12GDU

Listings

STU
DE
HQE1.STU
BOATS
BOATS
CTSO.BOATS
MU
DE
HQE1.MU
F
DE
HQE1.F

0 Comments

Share your thoughts

FAQ

What is Cytosorbents stock price today?▼
The current price of CTSO is $0.35 USD — it has increased by +0.03% in the past 24 hours. Watch Cytosorbents stock price performance more closely on the chart.
What is Cytosorbents stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cytosorbents stocks are traded under the ticker CTSO.
Is Cytosorbents stock price growing?▼
CTSO stock has risen by +4.32% compared to the previous week, the month change is a -7.23% fall, over the last year Cytosorbents has showed a -64.11% decrease.
What is Cytosorbents market cap?▼
Today Cytosorbents has the market capitalization of 22M
When is the next Cytosorbents earnings date?▼
Cytosorbents is going to release the next earnings report on October 29, 2026.
What were Cytosorbents earnings last quarter?▼
CTSO earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.05 USD resulting in a -11.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cytosorbents revenue for the last year?▼
Cytosorbents revenue for the last year amounts to 37.06M USD.
What is Cytosorbents net income for the last year?▼
CTSO net income for the last year is -8.2M USD.
How many employees does Cytosorbents have?▼
As of September 04, 2026, the company has 129 employees.
In which sector is Cytosorbents located?▼
Cytosorbents operates in the Health & Wellness sector.
When did Cytosorbents complete a stock split?▼
The last stock split for Cytosorbents was on December 05, 2014 with a ratio of 1:25.
Where is Cytosorbents headquartered?▼
Cytosorbents is headquartered in PRINCETON, United States.